EUCTR2020-000050-10-DK进行中（未招募）1 期
Finding the Optimal Regimen for Mycobacterium abscessus Treatment - FORMaT
niversity of Queensland0 个研究点目标入组 300 人开始时间: 2021年12月22日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Intervention Programs Inclusion Criteria
- •Eligible participants with mixed NTM infections (slow growers + MABS) or with recurrence of MABS infection following completion of previously successful treatment defined as remaining free of positive respiratory cultures for MABS over 12 months post treatment, will be eligible if they met the inclusion criteria listed below:
- •1.Positive MABS-PD diagnosis meeting all three American Thoracic Society clinical, radiological and microbiological diagnostic criteria for MABS-PD. Defined as;
- •a.Clinical: Pulmonary symptoms and exclusion of other diagnoses.
- •b.Radiological: Nodular or cavitary opacities on chest radiograph or a chest high-resolution computed tomography (HRCT) scan showing multifocal bronchiectasis with multiple small nodules.
- •c.Microbiological: MABS positive culture results from at least two separate expectorated sputum samples, Or;
- •d.Positive culture results from at least one bronchial wash or lavage, Or;
- •e.Transbronchial or other lung biopsy with mycobacterial histopathologic features (granulomatous inflammation or acid-fast bacilli (AFB)) and positive culture for NTM or biopsy showing mycobacterial histopathologic features (granulomatous inflammation or AFB) and one or more sputum or bronchial washes that are culture positive for NTM.
- •2.Male or female participants in Denmark aged 18 years and older, in other countries children are included.
- •3.Participant has not received treatment for MABS-PD in the 12 months preceding assessment of eligibility.
- •4.Informed consent signed by participant or parent/legal guardian if participant is under 18 years of age.
- •5.Ability to comply with study visits, therapies and study procedures as judged by the site investigator.
- •Observational Cohort Inclusion Criteria
- •1-Male and female participants of any age with at least one positive respiratory culture for MABS.
- •2- Informed consent signed by participant or parent/legal guardian if participant is under 18 years of age.
- •3-Ability to comply with study visits and study procedures as judged by the site investigator. Potential participants are eligible for the Intervention program (above) if the criteria below
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 40
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 110
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 150
排除标准
- •Intervention Program participants
- •Pregnant or breastfeeding
- •QTc interval >500 milliseconds
- •Received active treatment for MABS in the previous 12 months, except use of azithromycin as part of routine treatment for CF and bronchiectasis, will be excluded from the trial.
- •Observational Cohort participants
- •Received active treatment for MABS in the previous 12 months, except use of azithromycin as part of routine treatment for CF and bronchiectasis, will be excluded from the trial.
研究者
相似试验
招募中
2 期
Finding the Optimal Regimen for Mycobacterium abscessus Treatment (FORMaT)Mycobacterium abscessus pulmonary diseaseMycobacterium abscessusRespiratory - Other respiratory disorders / diseasesHuman Genetics and Inherited Disorders - Cystic fibrosisInfection - Other infectious diseasesACTRN12618001831279The University of Queensland300
进行中（未招募）
1 期
Finding the best treatment for lung disease from infection with Mycobacterium abscessusMycobacterium abscessus pulmonary diseaseMedDRA version: 20.1Level: PTClassification code: 10064789Term: Mycobacterium abscessus infection Class: 100000004862CTIS2023-506575-99-00The University Of Queensland300
招募中
2 期
Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentPulmonary Disease Due to Mycobacteria (Diagnosis)NCT04310930The University of Queensland300
已完成
不适用
Observational study for nontuberculous mycobacterial lung disease and non-cystic fibrosis bronchiectasisJPRN-UMIN000026487Keio University School of Medicine1,000
招募中
1 期
The plan of optimizing Helicobacter pylori eradicatioHelicobacter pylori infectionITMCTR1900002441Hubei Provincial Hospital of Traditional Chinese Medicine